Dipeptidyl Peptidase 4 Inhibitor class drugs

8 results

  • janumet

    (SITAGLIPTIN and METFORMIN HYDROCHLORIDE)
    Merck Sharp & Dohme LLC
    JANUMET is indicated for improving glycemic control in adults with type 2 diabetes as an adjunct to diet and exercise. It should not be used in type 1 diabetes and has not been studied in patients with a history of pancreatitis.
    Medication Details
    Drug Interactions

  • janumet

    (sitagliptin and metformin hydrochloride)
    Merck Sharp & Dohme LLC
    JANUMET XR is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not for use in patients with type 1 diabetes or those with a history of pancreatitis.
    Medication Details
    Drug Interactions

  • januvia

    (sitagliptin)
    Merck Sharp & Dohme LLC
    JANUVIA® is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It should not be used in type 1 diabetes and has not been studied in patients with a history of pancreatitis.
    Medication Details
    Drug Interactions

  • jentadueto

    (linagliptin and metformin hydrochloride)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    JENTADUETO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes or a history of pancreatitis, as its effects in these populations are unclear.
    Medication Details
    Drug Interactions

  • steglujan

    (ertugliflozin and sitagliptin)
    Merck Sharp & Dohme LLC
    STEGLUJAN® is indicated to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise. It is not recommended for type 1 diabetes or in patients with a history of pancreatitis due to unknown risks.
    Medication Details
    Drug Interactions

  • tradjenta

    (linagliptin)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    TRADJENTA is indicated for improving glycemic control in adults with type 2 diabetes mellitus, alongside diet and exercise. It is not recommended for type 1 diabetes patients and has not been studied in those with a history of pancreatitis.
    Medication Details
    Drug Interactions

  • zituvimet xr

    (sitagliptin and metformin hydrochloride)
    Zydus Pharmaceuticals USA Inc.
    ZITUVIMET XR is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes or those with a history of pancreatitis, as its safety in such populations is not established.
    Medication Details
    Drug Interactions